Table 1: Triage & Prioritization of breast tumour cases for surgery tailored to local case-mix (adapted from ACS [11], ESMO [12]) (ACS-American College of Surgeons, ESMO-European Society of Medical Oncology).
| Breast tumour | |
| High priority | Completed post-neoadjuvant chemotherapy |
| Complications of prior breast cancer surgery with bleeding or infection requiring re-intervention | |
| Complications from reconstructive surgery | |
| Breast cancer diagnosed in pregnancy | |
| Unusual cases for special considerations: Patients with progressive disease on systemic therapy, angiosarcoma, and malignant phyllodes, bleeding/ruptured tumours |
|
| Triple negative /HER2+* | |
| High grade DCIS | |
| Discordant biopsy of likely to be malignant | |
| Medium priority | Malignant or local recurrence |
| Axillary surgery staging | |
| Low priority | Low grade DCIS |
| Discordant biopsy likely benign | |
| Breast reconstruction (autologous/implant) | |
| Excision of benign breast lesion | |
| Prophylactic surgery for high risk asymptomatic patients | |
* Triple negative in patients who were either not indicated or not fit for systemic chemotherapy